Healthcare provider profile · identity verified

Sean E Secord, P.A.

Physician Assistant · DELHI, NY · NPI 1295780633

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	285	101
Levothyroxine Sodium	Levothyroxine Sodium	277	90
Rosuvastatin Calcium	Rosuvastatin Calcium	249	87
Lisinopril	Lisinopril	183	63
Losartan Potassium	Losartan Potassium	147	54
Pantoprazole Sodium	Pantoprazole Sodium	143	49
Amlodipine Besylate	Amlodipine Besylate	140	52
Hydrochlorothiazide	Hydrochlorothiazide	138	51
Glipizide Er	Glipizide	129	40
Metoprolol Succinate	Metoprolol Succinate	127	47
Gabapentin	Gabapentin	109	36
Fluticasone Propionate	Fluticasone Propionate	107	50
Tamsulosin Hcl	Tamsulosin Hcl	103	43
Metformin Hcl Er	Metformin Hcl	100	39
Famotidine	Famotidine	92	34
Sertraline Hcl	Sertraline Hcl	89	30
Jardiance	Empagliflozin	87	30
Eliquis	Apixaban	84	26
Omeprazole	Omeprazole	83	27
Trazodone Hcl	Trazodone Hcl	70	23
Alendronate Sodium	Alendronate Sodium	69	25
Synthroid	Levothyroxine Sodium	69	21
Finasteride	Finasteride	63	27
Allopurinol	Allopurinol	62	24
Montelukast Sodium	Montelukast Sodium	60	23
Trulicity	Dulaglutide	56	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	53	22
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	52	22
Potassium Chloride	Potassium Chloride	50	19
Furosemide	Furosemide	49	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	49	16
Alprazolam	Alprazolam	46	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	45	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	44	15
Metformin Hcl	Metformin Hcl	44	15
Albuterol Sulfate Hfa	Albuterol Sulfate	43	18
Diclofenac Sodium	Diclofenac Sodium	42	26
Torsemide	Torsemide	42	16
Ezetimibe	Ezetimibe	39	13
Simvastatin	Simvastatin	39	16
Duloxetine Hcl	Duloxetine Hcl	36	19
Naproxen	Naproxen	35	12
Tizanidine Hcl	Tizanidine Hcl	35	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	33	suppressed
Pravastatin Sodium	Pravastatin Sodium	33	15
Atenolol	Atenolol	29	suppressed
Bupropion Xl	Bupropion Hcl	29	suppressed
Buspirone Hcl	Buspirone Hcl	27	suppressed
Lorazepam	Lorazepam	27	14
Raloxifene Hcl	Raloxifene Hcl	27	12
Ropinirole Hcl	Ropinirole Hcl	27	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	26	22
Azithromycin	Azithromycin	25	23
Carvedilol	Carvedilol	25	suppressed
Propranolol Hcl Er	Propranolol Hcl	25	suppressed
Meloxicam	Meloxicam	24	11
Nystatin	Nystatin	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	17
Propranolol Hcl	Propranolol Hcl	22	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	22	suppressed
Celecoxib	Celecoxib	21	suppressed
Ramipril	Ramipril	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	19
Doxycycline Hyclate	Doxycycline Hyclate	20	19
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	19	suppressed
Prednisone	Prednisone	19	16
Nortriptyline Hcl	Nortriptyline Hcl	18	suppressed
Citalopram Hbr	Citalopram Hydrobromide	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Mometasone Furoate	Mometasone Furoate	16	11
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Clopidogrel	Clopidogrel Bisulfate	15	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Cephalexin	Cephalexin	13	13
Pregabalin	Pregabalin	13	suppressed
Spironolactone	Spironolactone	13	suppressed
Testosterone	Testosterone	13	suppressed
Tramadol Hcl	Tramadol Hcl	13	suppressed
Lactulose	Lactulose	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Clonazepam	Clonazepam	11	suppressed
Colchicine	Colchicine	11	suppressed
Dutasteride	Dutasteride	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error